QIM
WST icon

Quantitative Investment Management’s West Pharmaceutical WST Stock Holding History

Quantitative Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,528
Closed -$3.64M – 540
2026
Q1 		$3.64M Buy
14,528
+10,928
+304% +$2.72M 0.38% 77
2025
Q4 		$990K Buy
3,600
+2,191
+156% +$599K 0.1% 209
2025
Q3 		$369K Buy
+1,409
New +$342K 0.05% 260
2025
Q2 		– Sell
-18,568
Closed -$4.16M – 488
2025
Q1 		$4.16M Buy
18,568
+17,755
+2,184% +$4.89M 0.38% 57
2024
Q4 		$266K Sell
813
-421
-34% -$132K 0.02% 297
2024
Q3 		$370K Buy
+1,234
New +$378K 0.04% 265
2024
Q1 		– Sell
-921
Closed -$324K – 393
2023
Q4 		$324K Buy
+921
New +$326K 0.02% 299
2021
Q3 		– Sell
-629
Closed -$225K – 585
2021
Q2 		$225K Buy
+629
New +$208K 0.02% 355
2020
Q1 		– Sell
-2,734
Closed -$411K – 852
2019
Q4 		$411K Buy
+2,734
New +$398K 0.01% 547
2019
Q3 		– Sell
-4,765
Closed -$596K – 792
2019
Q2 		$596K Buy
4,765
+1,865
+64% +$220K 0.02% 496
2019
Q1 		$319K Buy
2,900
+500
+21% +$52K 0.02% 550
2018
Q4 		$235K Buy
+2,400
New +$260K 0.01% 478

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Quantitative Investment Management's WST Position: Q2 2026 in Review

Quantitative Investment Management sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 14,528 shares — an estimated $3.64M sold.

Quantitative Investment Management first reported a position in WST in Q4 2018 and held it in 12 quarters. The position peaked at $4.16M in Q1 2025. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Quantitative Investment Management reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Quantitative Investment Management sold 14,528 West Pharmaceutical shares in Q2 2026, an estimated $3.64M.
  • Quantitative Investment Management first reported a position in West Pharmaceutical in Q4 2018 and held it in 12 quarters.
  • Quantitative Investment Management's West Pharmaceutical position peaked at $4.16M in Q1 2025.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.